New Chinese Distributor Will Also Invest in At-The-Market Private Placement TEL AVIV, Israel, Feb. 03, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of the stroke caused by carotid artery disease, today announced a transaction intended to achieve […]
Author: Ken Dropiewski
SpectraWAVE Announces $13.2 Million Series A-2 Financing from Existing Investors to Bring Intracoronary Imaging Technology to Market
Funds will accelerate development and support regulatory filing BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc. today announced a $13.2 million Series A-2 financing to support completion of product development and regulatory filing for its flagship intracoronary imaging product, designed to help physicians optimize coronary stenting interventions and limit future adverse events. The funding […]
STS 2021 presents results of a large clinical study showing 79% survival with Impella 5.5 with SmartAssist
Danvers, Mass .- ( BUSINESS WIRE ) -Abiomed (NASDAQ: ABMD) is a large target of 356 patients treated with Impella 5.5 with SmartAssist at 16 facilities in the United States and Germany. A large study announced that the survival rate at withdrawal from support was 79%. The majority of surviving patients recovered autologous heart function and did not require additional mechanical […]
CVR Medical Corp. Plans Addition to Board of Directors
Vancouver, British Columbia–(Newsfile Corp. – February 2, 2021) – CVR Medical Corp. (TSXV: CVM) (OTC: CRRVF) (“CVR Medical” or the “Company” or “we“) a Canadian listed and US based healthcare company in the medical device market intends to diversify its’ Directors which is subject to approval at the Annual Shareholders’ Meeting. Harvey […]
Windtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical Development
WARRINGTON, Pa., Feb. 1, 2021 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointment of Joseph Soffer, M.D., F.A.C.C., as Executive Director of Clinical Development, effective immediately. “We are thrilled to welcome Joe […]
BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP™ System
Westport, CT, Feb. 02, 2021 (GLOBE NEWSWIRE) — Global market for AI in healthcare is estimated to reach $45.2 billion by 2026 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full […]
AliveCor Now Detects Six Times as Many Cardiac Conditions as Any Other Personal ECG
Launch of expanded range of determinations cements AliveCor as the most comprehensive AI-enabled solution in personal ECG MOUNTAIN VIEW, Calif., Feb. 1, 2021 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today launched an expanded range of ECG determinations on its KardiaMobile devices. These new determinations are cleared by […]
CardioFocus Announces Expanded Partnership With Japan Lifeline
HeartLight® X3 Japan Launch Anticipated in Mid-2021 MARLBOROUGH, Mass., Feb. 2, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has expanded its existing partnership agreement with Japan Lifeline Co., Ltd. (JLL). The agreement extends the timeframe of the existing distribution […]
JanOne Announces Closing of $6.0 Million Common Stock Offering
Net proceeds will help support planning of clinical trials for JAN101, the company’s lead drug candidate LAS VEGAS, Feb. 2, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the closing of previously announced its securities […]
Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs). This partnership brings together CSI’s leadership in the treatment of calcified arterial lesions with Dr. Philippe Marco, a pioneer […]
Recent
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
Atrium Therapeutics Reports First Quarter 2026 Financial Results
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Popular
- No commented posts yet